Phage display enables machine learning discovery of cancer antigen-specific TCRs

噬菌体展示技术可利用机器学习发现癌症抗原特异性T细胞受体

阅读:12
作者:Giancarlo Croce ,Rachid Lani ,Delphine Tardivon ,Sara Bobisse ,Mariastella de Tiani ,Maiia Bragina ,Marta A S Perez ,Justine Michaux ,Hui Song Pak ,Alexandra Michel ,Talita Gehret ,Julien Schmidt ,Philippe Guillame ,Michal Bassani-Sternberg ,Vincent Zoete ,Alexandre Harari ,Nathalie Rufer ,Michael Hebeisen ,Steven M Dunn ,David Gfeller

Abstract

T cells targeting epitopes in infectious diseases or cancer play a central role in spontaneous and therapy-induced immune responses. Epitope recognition is mediated by the binding of the T cell receptor (TCR), and TCRs recognizing clinically relevant epitopes are promising for T cell-based therapies. Starting from a TCR targeting the cancer-testis antigen NY-ESO-1157-165 epitope, we built large phage display libraries of TCRs with randomized complementary determining region 3 of the β chain. The TCR libraries were panned against NY-ESO-1, which enabled us to collect thousands of epitope-specific TCR sequences. Leveraging these data, we trained a machine learning TCR-epitope interaction predictor and identified several epitope-specific TCRs from TCR repertoires. Cellular assays revealed that the predicted TCRs displayed activity toward NY-ESO-1 and no detectable cross-reactivity. Our work demonstrates how display technologies combined with TCR-epitope interaction predictors can effectively leverage large TCR repertoires for TCR discovery.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。